Bone resorption by osteoclasts.

Osteoporosis, a disease endemic in Western society, typically reflects an imbalance in skeletal turnover so that bone resorption exceeds bone formation. Bone resorption is the unique function of the osteoclast, and anti-osteoporosis therapy to date has targeted this cell. The osteoclast is a specialized macrophage polykaryon whose differentiation is principally regulated by macrophage colony-stimulating factor, RANK ligand, and osteoprotegerin. Reflecting integrin-mediated signals, the osteoclast develops a specialized cytoskeleton that permits it to establish an isolated microenvironment between itself and bone, wherein matrix degradation occurs by a process involving proton transport. Osteopetrotic mutants have provided a wealth of information about the genes that regulate the differentiation of osteoclasts and their capacity to resorb bone.

[1]  D. Hewett‐Emmett,et al.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Matthew J. Silva,et al.  Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength , 2000, The Journal of cell biology.

[3]  K. Hruska,et al.  c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.

[4]  J. Thong,et al.  Automated three‐dimensional characterization of osteoclastic resorption lacunae by stereoscopic scanning electron microscopy , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  M. Cecchini,et al.  Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. , 1990, Endocrinology.

[6]  P. Schlesinger,et al.  Substrate Recognition by Osteoclast Precursors Induces C-src/Microtubule Association , 1997, The Journal of cell biology.

[7]  S. Teitelbaum,et al.  Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis , 1999 .

[8]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[9]  S. Krane,et al.  Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. , 1999, The Journal of clinical investigation.

[10]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[11]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[12]  I A Silver,et al.  Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. , 1988, Experimental cell research.

[13]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[14]  D. Lacey,et al.  Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. , 1999, Endocrinology.

[15]  S. K. Lee,et al.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. , 1999, Endocrinology.

[16]  D. Lacey,et al.  The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts , 1999, The Journal of cell biology.

[17]  X. Xie,et al.  Isolation and reconstitution of a vacuolar-type proton pump of osteoclast membranes. , 1994, The Journal of biological chemistry.

[18]  S. Teitelbaum,et al.  Successful bone-marrow transplantation for infantile malignant osteopetrosis. , 1980, The New England journal of medicine.

[19]  P. Schlesinger,et al.  Expression and Regulation of RAB3 Proteins in Osteoclasts and Their Precursors , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  E. Wagner,et al.  Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation , 2000, Nature Genetics.

[21]  M Horton,et al.  The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. , 1995, Journal of cell science.

[22]  R. Kitazawa,et al.  Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. , 1999, Biochimica et biophysica acta.

[23]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[24]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[25]  T. Sunyer,et al.  Estrogen’s bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells , 1999 .

[26]  M. Horton,et al.  A new specialized cell-matrix interaction in actively resorbing osteoclasts. , 2000, Journal of cell science.

[27]  M A Horton,et al.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. , 1997, The Journal of clinical investigation.

[28]  M. Horton,et al.  Trafficking of matrix collagens through bone-resorbing osteoclasts. , 1997, Science.

[29]  S. Teitelbaum,et al.  Osteoclastic bone resorption by a polarized vacuolar proton pump. , 1989, Science.

[30]  D. Lacey,et al.  Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1. , 1999, Endocrinology.

[31]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[32]  T. Martin,et al.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Y. Oike,et al.  Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation. , 1999, The American journal of pathology.

[34]  S. Mckercher,et al.  Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 , 1997, Nature.

[35]  S. Teitelbaum,et al.  Isolated osteoclasts resorb the organic and inorganic components of bone , 1986, The Journal of cell biology.

[36]  G. Rodan,et al.  PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. , 1998, The Journal of clinical investigation.

[37]  G. Mundy,et al.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.

[38]  Yuqiong Liang,et al.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification , 1999, Nature Genetics.

[39]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[40]  S. Teitelbaum,et al.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. , 1997, The Journal of clinical investigation.

[41]  E. Wagner,et al.  c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. , 1994, Science.

[42]  Josef M. Penninger,et al.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.

[43]  H. Varmus,et al.  Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice. , 1997, Genes & development.

[44]  G. Rodan,et al.  Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis , 1999, The Journal of Biological Chemistry.

[45]  F. Ross,et al.  Estrogen Deficiency Increases the Ability of Stromal Cells to Support Murine Osteoclastogenesis via an Interleukin-1and Tumor Necrosis Factor-mediated Stimulation of Macrophage Colony-stimulating Factor Production* , 1996, The Journal of Biological Chemistry.

[46]  R. Hynes,et al.  Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. , 2000, The Journal of clinical investigation.

[47]  L. Naldini,et al.  Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures , 1984, The Journal of cell biology.

[48]  I. Kola,et al.  Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  D. Lacey,et al.  Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells , 1999 .

[50]  Ulrich Siebenlist,et al.  Requirement for NF-κB in osteoclast and B-cell development , 1997 .

[51]  T. Yoneda,et al.  Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. , 1992, The Journal of clinical investigation.

[52]  P. Schlesinger,et al.  Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts. , 1989, The Journal of clinical investigation.

[53]  P. Schlesinger,et al.  Characterization of the Osteoclast Ruffled Border Chloride Channel and Its Role in Bone Resorption* , 1997, The Journal of Biological Chemistry.